US Stock MarketDetailed Quotes

GLSI Greenwich LifeSciences

Watchlist
  • 12.620
  • -0.520-3.96%
Close Apr 24 16:00 ET
  • 13.490
  • +0.870+6.89%
Pre 08:00 ET
162.53MMarket Cap-18289P/E (TTM)

Greenwich LifeSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
16.01%9.33M
-2.03%2.84M
5.03%2.5M
126.02%1.75M
12.66%2.24M
74.87%8.04M
21.77%2.89M
174.96%2.38M
2.64%773.31K
231.20%1.99M
Selling and administrative expenses
4.13%1.63M
15.23%503.05K
-47.73%344.76K
162.94%368.26K
25.82%413.18K
50.67%1.56M
39.35%436.58K
214.69%659.57K
-28.87%140.06K
3.06%328.38K
-General and administrative expense
4.13%1.63M
15.23%503.05K
-47.73%344.76K
162.94%368.26K
25.82%413.18K
50.67%1.56M
39.35%436.58K
214.69%659.57K
-28.87%140.06K
3.06%328.38K
Research and development costs
18.89%7.7M
-5.09%2.33M
25.22%2.16M
117.86%1.38M
10.06%1.83M
81.93%6.48M
19.10%2.46M
162.29%1.72M
13.78%633.25K
488.99%1.66M
Operating profit
-16.01%-9.33M
2.03%-2.84M
-5.03%-2.5M
-126.02%-1.75M
-12.66%-2.24M
-74.87%-8.04M
-21.77%-2.89M
-174.96%-2.38M
-2.64%-773.31K
-231.20%-1.99M
Net non-operating interest income expense
102.80%436.06K
-14.28%89.29K
73.55%111.14K
338.62%119.45K
493.51%116.18K
685.68%215.02K
531.30%104.17K
1,694.76%64.04K
636.05%27.23K
444.05%19.58K
Non-operating interest income
102.80%436.06K
-14.28%89.29K
73.55%111.14K
338.62%119.45K
493.51%116.18K
685.68%215.02K
531.30%104.17K
1,694.76%64.04K
636.05%27.23K
444.05%19.58K
Other net income (expense)
Income before tax
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
-168.68%-2.32M
0.49%-746.07K
-229.92%-1.97M
Income tax
Net income
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
-168.68%-2.32M
0.49%-746.07K
-229.92%-1.97M
Net income continuous Operations
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
-168.68%-2.32M
0.49%-746.07K
-229.92%-1.97M
Minority interest income
Net income attributable to the parent company
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
-168.68%-2.32M
0.49%-746.07K
-229.92%-1.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-13.63%-8.89M
1.57%-2.75M
-3.14%-2.39M
-118.26%-1.63M
-7.88%-2.12M
-71.21%-7.83M
-18.21%-2.79M
-168.68%-2.32M
0.49%-746.07K
-229.92%-1.97M
Basic earnings per share
-13.11%-0.69
4.55%-0.21
-5.56%-0.19
-116.67%-0.13
-13.33%-0.17
-74.29%-0.61
-22.22%-0.22
-157.14%-0.18
0.00%-0.06
-200.00%-0.15
Diluted earnings per share
-13.11%-0.69
4.55%-0.21
-5.56%-0.19
-116.67%-0.13
-13.33%-0.17
-74.29%-0.61
-22.22%-0.22
-157.14%-0.18
0.00%-0.06
-200.00%-0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 16.01%9.33M-2.03%2.84M5.03%2.5M126.02%1.75M12.66%2.24M74.87%8.04M21.77%2.89M174.96%2.38M2.64%773.31K231.20%1.99M
Selling and administrative expenses 4.13%1.63M15.23%503.05K-47.73%344.76K162.94%368.26K25.82%413.18K50.67%1.56M39.35%436.58K214.69%659.57K-28.87%140.06K3.06%328.38K
-General and administrative expense 4.13%1.63M15.23%503.05K-47.73%344.76K162.94%368.26K25.82%413.18K50.67%1.56M39.35%436.58K214.69%659.57K-28.87%140.06K3.06%328.38K
Research and development costs 18.89%7.7M-5.09%2.33M25.22%2.16M117.86%1.38M10.06%1.83M81.93%6.48M19.10%2.46M162.29%1.72M13.78%633.25K488.99%1.66M
Operating profit -16.01%-9.33M2.03%-2.84M-5.03%-2.5M-126.02%-1.75M-12.66%-2.24M-74.87%-8.04M-21.77%-2.89M-174.96%-2.38M-2.64%-773.31K-231.20%-1.99M
Net non-operating interest income expense 102.80%436.06K-14.28%89.29K73.55%111.14K338.62%119.45K493.51%116.18K685.68%215.02K531.30%104.17K1,694.76%64.04K636.05%27.23K444.05%19.58K
Non-operating interest income 102.80%436.06K-14.28%89.29K73.55%111.14K338.62%119.45K493.51%116.18K685.68%215.02K531.30%104.17K1,694.76%64.04K636.05%27.23K444.05%19.58K
Other net income (expense)
Income before tax -13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M-168.68%-2.32M0.49%-746.07K-229.92%-1.97M
Income tax
Net income -13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M-168.68%-2.32M0.49%-746.07K-229.92%-1.97M
Net income continuous Operations -13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M-168.68%-2.32M0.49%-746.07K-229.92%-1.97M
Minority interest income
Net income attributable to the parent company -13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M-168.68%-2.32M0.49%-746.07K-229.92%-1.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -13.63%-8.89M1.57%-2.75M-3.14%-2.39M-118.26%-1.63M-7.88%-2.12M-71.21%-7.83M-18.21%-2.79M-168.68%-2.32M0.49%-746.07K-229.92%-1.97M
Basic earnings per share -13.11%-0.694.55%-0.21-5.56%-0.19-116.67%-0.13-13.33%-0.17-74.29%-0.61-22.22%-0.22-157.14%-0.180.00%-0.06-200.00%-0.15
Diluted earnings per share -13.11%-0.694.55%-0.21-5.56%-0.19-116.67%-0.13-13.33%-0.17-74.29%-0.61-22.22%-0.22-157.14%-0.180.00%-0.06-200.00%-0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg